Everyone loves a good comeback story. Probably because it leaves us feeling inspired and full of hope. But the comeback story about a horse named Dream Alliance may do more than that: his experience promises to help people with Achilles tendon injuries get fully healed and back on their feet more quickly. Dream Alliance was … Continue reading A horse, stem cells and an inspiring comeback story that may revolutionize tendon repair
Stem cell research
Building the World’s Largest iPSC Repository: An Interview with CIRM’s Stephen Lin
This blog originally appeared on RegMedNet and was provided by Freya Leask, Editor & Community Manager of RegMedNet. In this interview, Stephen Lin, Senior Science Officer at the California Institute Regenerative Medicine (CIRM), discusses the scope, challenges and potential of CIRM’s iPSC Initiative. Stephen Lin received his PhD from Washington University (MO, USA) and completed his postdoctoral … Continue reading Building the World’s Largest iPSC Repository: An Interview with CIRM’s Stephen Lin
A Clinical Trial Network Focused on Stem Cell Treatments is Expanding
Geoff Lomax is a Senior Officer of CIRM's Strategic Initiatives. California is one of the world-leaders in advancing stem cell research towards treatments and cures for patients with unmet medical needs. California has scientists at top universities and companies conducting cutting edge research in regenerative medicine. It also has CIRM, California’s Stem Cell Agency, which … Continue reading A Clinical Trial Network Focused on Stem Cell Treatments is Expanding
3D printing blood vessels: a key step to solving the organ donor crisis
About 120,000 people in the U.S. are on a waiting list for an organ donation and every day 22 of those people will die because there aren’t enough available organs. To overcome this organ donor crisis, bioengineers are working hard to develop 3D printing technologies that can construct tissues and organs from scratch by using … Continue reading 3D printing blood vessels: a key step to solving the organ donor crisis
License to heal: UC Davis deal looks to advance stem cell treatment for bone loss and arthritis
There are many challenges in taking even the most promising stem cell treatment and turning it into a commercial product approved by the Food and Drug Administration (FDA). One of the biggest is expertise. The scientists who develop the therapy may be brilliant in the lab but have little experience or expertise in successfully getting … Continue reading License to heal: UC Davis deal looks to advance stem cell treatment for bone loss and arthritis
Could Stem Cells Help Beat Multiple Sclerosis?
March is Multiple Sclerosis month. In honor of MS patients and research, we are featuring a guest blog from scientist and communicator Hamideh Emrani. Thoughts expressed here are not necessarily those of CIRM. If you are reading this post, other than out of curiosity, chances are that you know someone who has been affected by … Continue reading Could Stem Cells Help Beat Multiple Sclerosis?
Stem cell stories that caught our eye: building an embryo and reviving old blood stem cells
Building an embryo in the lab from stem cells The human body has been studied for centuries yet little is known about the first 14 days of human development when the fertilized embryo implants into the mother’s uterus and begins to divide and grow. Being able to precisely examine this critical time window may help … Continue reading Stem cell stories that caught our eye: building an embryo and reviving old blood stem cells
Reducing animal testing with stem cells and electronic petri dishes
Though the celebrities at Sunday’s Academy Awards worked hard to sport unique clothing and hair styles, I bet many had something in common: Botox injections. Botox, an FDA-approved, marketed form of Botulism neurotoxin, is well known for its wrinkle reducing effects. The neurotoxin’s other claim to fame is the fact that it’s the most lethal, … Continue reading Reducing animal testing with stem cells and electronic petri dishes
Raising awareness about Rare Disease Day
One of the goals we set ourselves at CIRM in our 2016 Strategic Plan was to fund 50 new clinical trials over the next five years, including ten rare or orphan diseases. Since then we have funded 13 new clinical trials including four targeting rare diseases (retinitis pigmentosa, severe combined immunodeficiency, ALS or Lou Gehrig’s … Continue reading Raising awareness about Rare Disease Day
Partnering with the best to help find cures for rare diseases
As a state agency we focus most of our efforts and nearly all our money on California. That’s what we were set up to do. But that doesn’t mean we don’t also look outside the borders of California to try and find the best research, and the most promising therapies, to help people in need. … Continue reading Partnering with the best to help find cures for rare diseases
The Stem Cellar 